Latest news
AstraZeneca (LSE:AZN) Stock Could Sit Below Fair Value Despite Strong Returns - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:58:41 GMTBiotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure? - StocktwitsStocktwits · Fri, 07 Aug 2026 02:10:28 GMTWhat the AstraZeneca-BMS rumors reveal about pharma megamergers - Pharma VoicePharma Voice · Thu, 06 Aug 2026 13:40:22 GMTMergers as Strategic Architecture: Rethinking How to Evaluate the AstraZeneca–BMS Rumors - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 10:02:44 GMTAstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMTAstraZeneca, CSPC to form joint venture for biologics manufacturing - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 19:22:05 GMTAstraZeneca-Bristol Myers Merger Denied: What It Exposed - OncodailyOncodaily · Wed, 05 Aug 2026 16:54:25 GMTBeyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 15:17:36 GMT